North America Embolization Agents Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product (Coils, Plugs, Beads/ Particles, Detachable Balloons, Glue, Sponge, Liquid Embolics, Sclerosants, Precipitating Agents, and Others), Application (Oncology, Neurology, Urology, Cardiology, Peripheral Vascular Diseases, and Others), and End User (Hospitals, Cardiac Centers, Ambulatory Surgical Centers, and Others)
Market Introduction
The North America embolization agents market is divided into the US, Canada, and Mexico. The growth of market is widely attributed by the increasing incidences of the neurological disorders such as stroke, brain aneurysms and others across the country. Moreover, the growth of market in Canada is expected to grow due to increasing support from the government to address the rising concerns about the brain diseases. In addition, across the Mexico the market is estimated to grow due to the increasing medical industries and increasing export of medical devices to US and other countries. The embolization agents market is anticipated to grow significantly owing to the rising cases of brain aneurysm. According to the Brain Aneurysm Foundation’s report, approximately 6 million people have unruptured brain aneurysm in the US. Also, the annual rate of rupture is nearly 8 – 10 per 100,000 people, approximately 30,000 people in the country who suffer from a brain aneurysm rupture. In addition, about 4 out of 7 people who recover from a ruptured brain aneurysm are likely to suffer from the disabilities. This neurological disorder generally affects people who are in the age group of 35 – 60 years. However, the brain aneurysm can also be seen in children, the women in the country suffer more than men. Despite the wide availability of brain imaging screening, delays in diagnosis often lead to deteriorating health conditions. Therefore, technological advancements in the development of advanced and less invasive techniques for early diagnosis are bolstering the new product innovation in the country. The companies are launching various products for embolization. These companies are aggressively involved in the developments and are receiving various product approvals from the FDA. For instance, in 2019, MicroVention, Inc. received Premarket Approval from the FDA for the WEB Aneurysm Embolization System. The WEB System is the first of its kind intrasaccular flow disruptor for aneurysm embolization. In July 2021, Terumo Medical Corporation recently launched its AZUR Vascular Plug, the first and only plug compatible with a microcatheter to occlude arteries up to 8mm in diameter. This addition to the embolization portfolio is indicated to reduce or block the rate of blood flow in arteries of the peripheral vasculature.
The United States has the highest number of COVID-19 cases in North America. The epidemic has caused havoc in the medical industry in North American countries, with demand for diagnostic and therapeutic assistance to combat the sickness skyrocketing. Furthermore, the COVID-19 pandemic is posing unprecedented operational and clinical problems to healthcare institutions in the region. Furthermore, a shift in focus from cardiovascular therapy to COVID-19 therapeutic services resulted in a reduction in the growth of the North American embolization agents market in 2020. COVID patients with comorbidities including CVDs and hypertension require critical ICU resources and are at a high risk of developing further problems. As a result, most hospitals and surgical centres have considered cancelling or deferring elective surgery, such as cardiovascular procedures. There was a 52.7 percent decline in adult cardiac surgery volume and a 65.5 percent reduction in elective cases in the United States, according to the Society of Thoracic Surgeons Adult Cardiac Surgery Database and the Johns Hopkins COVID-19 database. Following the first COVID-19 surge, nationwide cardiac surgical case volumes decreased, indicating a COVID-19-related impact on heart surgery patients. In the long run, however, with the widespread deployment of vaccination campaigns and a drop in the transmission rate, healthcare systems are returning to normal, and demand for embolization products is projected to recover to normal in the future years.
Get more information on this report : 
Market Overview and Dynamics
The embolization agents market in North America is expected to grow from US$ 1,041.25 million in 2021 to US$ 1,763.73 million by 2028; it is estimated to grow at a CAGR of 7.8% from 2021 to 2028. Growing geriatric population base; growing geriatric population and the rise in associated neurological disorders and cancers, is likely to create growth opportunities for the market. The accumulation of health risks across a lifespan of disease, injury, and chronic illness contributes to higher disability rates among older people. As per the US Census Bureau, there were 54 million US residents with age 65 and above in the July 2019. Further, the Urban Institute estimated that number of US population belonging to this age group would reach 80 million by 2040. Thus, growing geriatric population base is likely to favor the growth of the North America embolization agents market.
Key Market Segments
Based on product, the market is segmented into coils, beads/particles, plugs, detachable balloons, glue, sponge, liquid embolics, sclerosants, precipitating agents, others. The beads/particles segment held the largest share of the market in 2020. Based on coils the market is divided into detachable coils and pushable coils. The pushable coils segment held the largest share of the market in 2020. Based on beads/particles the market is divided into spherical and non-spherical. The pushable non-spherical segment held the largest share of the market in 2020. Based on application, the market is segmented into neurology, oncology, cardiology, peripheral vascular diseases, and others. In 2020, the oncology segment is likely to hold the largest share of the market. The embolization agents market by end user, is segmented into hospitals, ambulatory surgical centers, cardiac centers, and others. The hospitals segment held the largest share of the market in 2020.
Major Sources and Companies Listed
A few major primary and secondary sources referred to for preparing this report on the embolization agents market in North America are company websites, annual reports, financial reports, national government documents, and statistical database, among others. Major companies listed in the report are Abbott; Boston Scientific Corporation; Cook Medical LLC; DePuy Synthes; KANEKA CORPORATION; Medtronic; Merit Medical Systems Inc; Penumbra, Inc.; Stryker Corporation; and Terumo Corporation among others.
Reasons to buy report
- To understand the North America embolization agents market landscape and identify market segments that are most likely to guarantee a strong return
- Stay ahead of the race by comprehending the ever-changing competitive landscape for North America embolization agents market
- Efficiently plan M&A and partnership deals in North America embolization agents market by identifying market segments with the most promising probable sales
- Helps to take knowledgeable business decisions from perceptive and comprehensive analysis of market performance of various segment form North America embolization agents market
- Obtain market revenue forecast for market by various segments from 2021-2028 in North America region.
NORTH AMERICA EMBOLIZATION AGENTS MARKET SEGMENTATION
- Coils
- Detachable Coils
- Pushable Coils
- Beads/ Particles
- Spherical
- Non-Spherical
- Plugs
- Detachable Balloons
- Glue
- Sponge
- Liquid Embolics
- Sclerosants
- Precipitating Agents
- Others
- Oncology
- Neurology
- Urology
- Cardiology
- Peripheral Vascular Diseases
- Others
- Hospitals
- Cardiac Centers
- Ambulatory Surgical Centers
- Others
By Country
- US
- Canada
- Mexico
Company Profiles
- Abbott
- Boston Scientific Corporation
- Cook Medical LLC
- DePuy Synthes
- KANEKA CORPORATION
- Medtronic
- Merit Medical Systems Inc
- Penumbra, Inc.
- Stryker Corporation
- Terumo Corporation
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 North America Embolization Agents Market – By Product
1.3.2 North America Embolization Agents Market – By Application
1.3.3 North America Embolization Agents Market – By End User
1.3.4 North America Embolization Agents Market – By Country
2. North America Embolization Agents Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. North America Embolization Agents Market – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 North America – PEST Analysis
4.3 Experts Opinion
5. North America Embolization Agents Market– Key Market Dynamics
5.1 Market Drivers
5.1.1 Rise in the Incidence of Tumors and Aneurysms
5.1.2 Growing Incidence of Hypertension, Obesity, Smoking, and Alcoholism
5.2 Market Restraints
5.2.1 High Cost of Embolization Agents
5.3 Market Opportunities
5.3.1 Growing Geriatric Population Base
5.4 Future Trends
5.4.1 Technological Advancements in Embolization Products and Procedures
5.5 Impact analysis
6. Embolization Agents Market – North America Analysis
6.1 North America Embolization Agents Market Revenue Forecast and Analysis
7. North America Embolization Agents Market Analysis – By Product
7.1 Overview
7.2 North America Embolization Agents Market Revenue Share, by Product (2021 and 2028)
7.3 Coils
7.3.1 Overview
7.3.2 Coils: North America Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)
7.3.2.1 Detachable Coils
7.3.2.1.1 Detachable Coil Market Revenue and Forecast to 2028 (US$ Mn)
7.3.2.1.2 Detachable Coil Market Revenue and Forecasts to 2028 (US$ Mn)
7.3.2.2 Pushable Coils
7.3.2.2.1 Pushable Coil Market Revenue and Forecast to 2028 (US$ Mn)
7.3.2.2.2 Pushable Coil Market Revenue and Forecasts to 2028 (US$ Mn)
7.4 Beads/Particles
7.4.1 Overview
7.4.2 Beads/Particles: North America Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)
7.4.2.1 Spherical
7.4.2.1.1 Spherical Market Revenue and Forecast to 2028 (US$ Mn)
7.4.2.1.2 Spherical Market Revenue and Forecasts to 2028 (US$ Mn)
7.4.2.2 Non-Spherical
7.4.2.2.1 Non-Spherical Market Revenue and Forecast to 2028 (US$ Mn)
7.4.2.2.2 Non-Spherical Market Revenue and Forecasts to 2028 (US$ Mn)
7.5 Plugs
7.5.1 Overview
7.5.2 Plugs: North America Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)
7.6 Detachable Balloons
7.6.1 Overview
7.6.2 Detachable Balloons: North America Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)
7.7 Glue
7.7.1 Overview
7.7.2 Glue: North America Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)
7.8 Sponge
7.8.1 Overview
7.8.2 Sponge: North America Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)
7.9 Liquid Embolics
7.9.1 Overview
7.9.2 Liquid Embolics: North America Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)
7.10 Sclerosants
7.10.1 Overview
7.10.2 Sclerosants: North America Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)
7.11 Precipitating Agents
7.11.1 Overview
7.11.2 Precipitating Agents: North America Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)
7.12 Others
7.12.1 Overview
7.12.2 Others: North America Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)
8. North America Embolization Agents Market Analysis – By Application
8.1 Overview
8.2 North America Embolization Agents Market, by Application 2021 & 2028 (%)
8.3 Oncology
8.3.1 Overview
8.3.2 Oncology: North America Embolization Agents Market – Revenue and Forecast to 2028 (US$ Million)
8.4 Neurology
8.4.1 Overview
8.4.2 Neurology: North America Embolization Agents Market – Revenue and Forecast to 2028 (US$ Million)
8.5 Urology
8.5.1 Overview
8.5.2 Urology: North America Embolization Agents Market – Revenue and Forecast to 2028 (US$ Million)
8.6 Cardiology
8.6.1 Overview
8.6.2 Cardiology: North America Embolization Agents Market – Revenue and Forecast to 2028 (US$ Million)
8.7 Peripheral Vascular Diseases
8.7.1 Overview
8.7.2 Peripheral Vascular Diseases: North America Embolization Agents Market – Revenue and Forecast to 2028 (US$ Million)
8.8 Others
8.8.1 Overview
8.8.2 Others: North America Embolization Agents Market – Revenue and Forecast to 2028 (US$ Million)
9. North America Embolization Agents Market Analysis – By End User
9.1 Overview
9.2 North America Embolization Agents Market Revenue Share, By End User (2021 and 2028)
9.3 Hospitals
9.3.1 Overview
9.3.2 Hospitals: North America Embolization Agents Market – Revenue and Forecast to 2028 (US$ Million)
9.4 Cardiac Centers
9.4.1 Overview
9.4.2 Cardiac Centers: North America Embolization Agents Market – Revenue and Forecast to 2028 (US$ Million)
9.5 Ambulatory Surgical Centers
9.5.1 Overview
9.5.2 Ambulatory Surgical Centers: North America Embolization Agents Market – Revenue and Forecast to 2028 (US$ Million)
9.6 Others
9.6.1 Overview
9.6.2 Others: North America Embolization Agents Market – Revenue and Forecast to 2028 (US$ Million)
10. North America Embolization Agents Market – Country Analysis
10.1 North America: Embolization Agents Market
10.1.1 Overview
10.1.2 North America: Embolization Agents Market, by Country, 2021 & 2028 (%)
10.1.2.1 US: Embolization Agents Market – Revenue and Forecast to 2028 (USD Million)
10.1.2.1.1 US: Embolization Agents Market – Revenue and Forecast to 2028 (USD Million)
10.1.2.1.2 US Embolization Agents Market, by Product – Revenue and Forecast to 2028 (USD Million)
10.1.2.1.2.1 US Embolization Agents Market, by Coil – Revenue and Forecast to 2028 (USD Million)
10.1.2.1.2.2 US Embolization Agents Market, by Beads/ Particles – Revenue and Forecast to 2028 (USD Million)
10.1.2.1.3 US Embolization Agents Market, By Application – Revenue and Forecast to 2028 (USD Million)
10.1.2.1.4 US Embolization Agents Market, by End User – Revenue and Forecast to 2028 (USD Million)
10.1.2.2 Canada: Embolization Agents Market – Revenue and Forecast to 2028 (USD Million)
10.1.2.2.1 Canada: Embolization Agents Market – Revenue and Forecast to 2028 (USD Million)
10.1.2.2.2 Canada Embolization Agents Market, by Product – Revenue and Forecast to 2028 (USD Million)
10.1.2.2.2.1 Canada Embolization Agents Market, by Coil – Revenue and Forecast to 2028 (USD Million)
10.1.2.2.2.2 Canada Embolization Agents Market, by Beads/ Particles – Revenue and Forecast to 2028 (USD Million)
10.1.2.2.3 Canada Embolization Agents Market, By Application – Revenue and Forecast to 2028 (USD Million)
10.1.2.2.4 Canada Embolization Agents Market, by End User – Revenue and Forecast to 2028 (USD Million)
10.1.2.3 Mexico: Embolization Agents Market – Revenue and Forecast to 2028 (USD Million)
10.1.2.3.1 Mexico: Embolization Agents Market – Revenue and Forecast to 2028 (USD Million)
10.1.2.3.2 Mexico Embolization Agents Market, by Product – Revenue and Forecast to 2028 (USD Million)
10.1.2.3.2.1 Mexico Embolization Agents Market, by Coil – Revenue and Forecast to 2028 (USD Million)
10.1.2.3.2.2 Mexico Embolization Agents Market, by Beads/ Particles – Revenue and Forecast to 2028 (USD Million)
10.1.2.3.3 Mexico Embolization Agents Market, By Application – Revenue and Forecast to 2028 (USD Million)
10.1.2.3.4 Mexico Embolization Agents Market, by End User – Revenue and Forecast to 2028 (USD Million)
11. Impact Of COVID-19 Pandemic on North America Embolization Agents Market
11.1 North America: Impact Assessment of COVID-19 Pandemic
12. North America Embolization Agents Market–Industry Landscape
12.1 Overview
12.2 Organic Developments
12.2.1 Overview
12.3 Inorganic Developments
12.3.1 Overview
13. Company Profiles
13.1 Medtronic
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Terumo Corporation
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 Cook Medical LLC
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Boston Scientific Corporation
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Abbott
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 Stryker Corporation
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 Penumbra, Inc.
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 Merit Medical Systems Inc.
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 DePuy Synthes
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
13.10 KANEKA CORPORATION
13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments
14. Appendix
14.1 About The Insight Partners
14.2 Glossary of Terms
LIST OF TABLES
Table 1. North America Embolization Agents Market – Revenue and Forecast to 2028 (US$ million)
Table 2. US Embolization Agents Market, by Product – Revenue and Forecast to 2028 (USD Million)
Table 3. US Embolization Agents Market, by Coil – Revenue and Forecast to 2028 (USD Million)
Table 4. US Embolization Agents Market, by Beads/ Particles – Revenue and Forecast to 2028 (USD Million)
Table 5. US Embolization Agents Market, By Application – Revenue and Forecast to 2028 (USD Million)
Table 6. US Embolization Agents Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 7. Canada Embolization Agents Market, by Product - Revenue and Forecast to 2028 (USD Million)
Table 8. Canada Embolization Agents Market, by Coil - Revenue and Forecast to 2028 (USD Million)
Table 9. Canada Embolization Agents Market, by Beads/ Particles - Revenue and Forecast to 2028 (USD Million)
Table 10. Canada Embolization Agents Market, By Application - Revenue and Forecast to 2028 (USD Million)
Table 11. Canada Embolization Agents Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 12. Mexico Embolization Agents Market, by Product – Revenue and Forecast to 2028 (USD Million)
Table 13. Mexico Embolization Agents Market, by Coil – Revenue and Forecast to 2028 (USD Million)
Table 14. Mexico Embolization Agents Market, by Beads/ Particles – Revenue and Forecast to 2028 (USD Million)
Table 15. Mexico Embolization Agents Market, By Application – Revenue and Forecast to 2028 (USD Million)
Table 16. Mexico Embolization Agents Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 17. Organic Developments Done by Companies
Table 18. Inorganic Developments Done by Companies
Table 19. Glossary of Terms, North America Embolization Agents Market
LIST OF FIGURES
Figure 1. North America Embolization Agents Market Segmentation
Figure 2. North America Embolization Agents Market Segmentation, By Country
Figure 3. North America Embolization Agents Market Overview
Figure 4. Beads/ Particles Segment Held the Largest Share of the Product Segment in North America Embolization Agents Market
Figure 5. US to Show Significant Growth During Forecast Period
Figure 6. North America PEST Analysis
Figure 7. North America Embolization Agents Market Impact Analysis of Drivers and Restraints
Figure 8. North America Embolization Agents Market – Revenue Forecast and Analysis – 2020- 2028
Figure 9. North America Embolization Agents Market Revenue Share, by Product (2021 and 2028)
Figure 10. Coils: North America Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)
Figure 11. Beads/Particles: North America Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)
Figure 12. Plugs: North America Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)
Figure 13. Detachable Balloons: North America Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)
Figure 14. Glue: North America Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)
Figure 15. Sponge: North America Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)
Figure 16. Liquid Embolics: North America Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)
Figure 17. Sclerosants: North America Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)
Figure 18. Precipitating Agents: North America Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)
Figure 19. Others: North America Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)
Figure 20. North America Embolization Agents Market, by Application 2021 & 2028 (%)
Figure 21. Oncology: North America Embolization Agents Market – Revenue and Forecast to 2028 (US$ Million)
Figure 22. Neurology: North America Embolization Agents Market – Revenue and Forecast to 2028 (US$ Million)
Figure 23. Urology: North America Embolization Agents Market – Revenue and Forecast to 2028 (US$ Million)
Figure 24. Cardiology: North America Embolization Agents Market – Revenue and Forecast to 2028 (US$ Million)
Figure 25. Peripheral Vascular Diseases: North America Embolization Agents Market – Revenue and Forecast to 2028 (US$ Million)
Figure 26. Others: North America Embolization Agents Market – Revenue and Forecast to 2028 (US$ Million)
Figure 27. North America Embolization Agents Market Revenue Share, By End User (2021 and 2028)
Figure 28. Hospitals: North America Embolization Agents Market – Revenue and Forecast to 2028 (US$ Million)
Figure 29. Cardiac Centers: North America Embolization Agents Market – Revenue and Forecast to 2028 (US$ Million)
Figure 30. Ambulatory Surgical Centers: North America Embolization Agents Market – Revenue and Forecast to 2028 (US$ Million)
Figure 31. Others: North America Embolization Agents Market – Revenue and Forecast to 2028 (US$ Million)
Figure 32. North America: Embolization Agents Market, by Key Country – Revenue (2021) (USD Million)
Figure 33. North America: Embolization Agents Market, by Country, 2021 & 2028 (%)
Figure 34. US: Embolization Agents Market – Revenue and Forecast to 2028 (USD Million)
Figure 35. Canada: Embolization Agents Market – Revenue and Forecast to 2028 (USD Million)
Figure 36. Mexico: Embolization Agents Market – Revenue and Forecast to 2028 (USD Million)
Figure 37. Impact of COVID-19 Pandemic in North American Country Markets
- Abbott
- Boston Scientific Corporation
- Cook Medical LLC
- DePuy Synthes
- KANEKA CORPORATION
- Medtronic
- Merit Medical Systems Inc
- Penumbra, Inc.
- Stryker Corporation
- Terumo Corporation
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the North America Embolization Agents Market.
- Highlights key business priorities in order to assist companies to realign their business strategies
- The key findings and recommendations highlight crucial progressive industry trends in the North America Embolization Agents Market, thereby allowing players across the value chain to develop effective long-term strategies
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
- Scrutinize in-depth North America market trends and outlook coupled with the factors driving the Embolization Agents Market, as well as those hindering it
- Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing and distribution